Literature DB >> 18466074

The FDA revises requirements for levothyroxine products.

Kenneth Burman1, James Hennessey, Michael McDermott, Leonard Wartofsky, Charles Emerson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18466074     DOI： 10.1089/thy.2008.0109

Source DB:  PubMed          Journal:  Thyroid        ISSN： 1050-7256            Impact factor:   6.568


× No keyword cloud information.
  2 in total

Review 1.  The emergence of levothyroxine as a treatment for hypothyroidism.

Authors:  James V Hennessey
Journal:  Endocrine       Date:  2016-12-16       Impact factor: 3.633

Review 2.  Levothyroxine Formulations: Pharmacological and Clinical Implications of Generic Substitution.

Authors:  Salvatore Benvenga; Allan Carlé
Journal:  Adv Ther       Date:  2019-09-04       Impact factor: 3.845
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.